Drug Database
N07BC51 buprenorphine, combinations
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Buprenorphine/Naloxone Ethypharm 2 mg/0.5 mg sublingual tablets
- POM Buprenorphine/Naloxone Ethypharm 8 mg/2 mg sublingual tablets
- POM Buprenorphine/Naloxone Mylan 2 mg/0.5 mg sublingual tablets
- POM Buprenorphine/Naloxone Mylan 8 mg/2 mg sublingual tablets
- POM Suboxone sublingual tablets
- POM Suboxone-sublingual-film
- POM Zubsolv 1.4mg/0.36mg sublingual Tablets
- POM Zubsolv 11.4 mg / 2.9 mg sublingual tablets
- POM Zubsolv 2.9 mg / 0.71 mg sublingual tablets
- POM Zubsolv 5.7 mg / 1.4 mg sublingual tablets
- POM Zubsolv 8.6 mg / 2.1 mg sublingual tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).